SYRINGE S2 10ML 21GA 1-1/2IN BD CHINA
Report
- Report Number
- 2243072-2019-02866
- Event Type
- Malfunction
- Date Received
- December 19, 2019
- Date of Event
- November 28, 2019
- Report Date
- December 31, 2019
- Manufacturer
- BECTON DICKINSON, S.A.
- Product Code
- FMF
- PMA / PMN Number
- N/A
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CH
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
Narratives
INVESTIGATION: BD HAS NOT BEEN PROVIDED WITH PHOTOS OR SAMPLES FOR CATALOG 301947 LOT 1812118 TO INVESTIGATE FOR THIS RECORD. UNFORTUNATELY, AS A RESULT, BD WAS UNABLE TO VERIFY THE REPORTED ISSUE OR DETERMINE A DEFINITIVE ROOT CAUSE. DHR SHOWED NO INDICATION OF THE ALLEGED DEFECT.
IT WAS REPORTED THAT LEAKAGE OCCURRED DURING USE WITH A SYRINGE S2 10ML 21GA 1-1/2IN BD CHINA. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER, "THE PATIENT WAS HOSPITALIZED IN OUR HOSPITAL, AND THE SYRINGE WAS USED FOR INTRAVENOUS INFUSION OF PHARMACEUTICAL LIQUID, BUT THE SYRINGE WAS LEAKING AND COULD NOT BE USED, THUS WASTING MEDICAL RESOURCES. THE PATIENT WAS IMMEDIATELY REPLACED WITH A NEW SYRINGE, AND THE TREATMENT CONTINUED."
A DEVICE EVALUATION IS ANTICIPATED, BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED.
IT WAS REPORTED THAT LEAKAGE OCCURRED DURING USE WITH A SYRINGE S2 10ML 21GA 1-1/2IN BD CHINA. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER, "THE PATIENT WAS HOSPITALIZED IN OUR HOSPITAL, AND THE SYRINGE WAS USED FOR INTRAVENOUS INFUSION OF PHARMACEUTICAL LIQUID, BUT THE SYRINGE WAS LEAKING AND COULD NOT BE USED, THUS WASTING MEDICAL RESOURCES. THE PATIENT WAS IMMEDIATELY REPLACED WITH A NEW SYRINGE, AND THE TREATMENT CONTINUED."
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1294482 | SYRINGE S2 10ML 21GA 1-1/2IN BD CHINA | SYRINGE | FMF | BECTON DICKINSON, S.A. | 1812118 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Other |